Kewaunee Scientific director gifts 2,750 shares

Kewaunee Scientific director Margaret B. Pyle reported a bona fide gift of 2,750 shares of common stock held indirectly through a trust.

Accepted by SEC EDGAR 03/27/2026 - 10:11 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Kewaunee Scientific director Margaret B. Pyle reported a bona fide gift of 2,750 shares of common stock held indirectly through a trust. The shares were transferred on March 26, 2026, as a gift to five grandchildren, with no sale proceeds involved. After the transfer, trust-related indirect holdings reported for her total 36,891 shares, and a separate 5,000 shares are reported as held indirectly by her spouse.

Insider Trade Summary

2,750 shares gifted

Gift 1 txn

Insider PYLE MARGARET B

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	2,750	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 36,891 shares (Indirect, By Trust); Common Stock — 5,000 shares (Indirect, By Spouse)

Footnotes (2)

1. F1. On March 26, 2026, the reporting person transferred 2,750 shares of common stock by gift to five of the reporting person's grandchildren.
2. F2. The reporting person disclaims beneficial ownership of these shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Margaret B. Pyle report for Kewaunee Scientific (KEQU)?

Director Margaret B. Pyle reported a bona fide gift of 2,750 Kewaunee Scientific common shares on March 26, 2026. The shares were held indirectly through a trust and were gifted to five of her grandchildren without sale proceeds.

How many Kewaunee Scientific (KEQU) shares did the trust associated with Margaret B. Pyle report after the gift?

Following the gift, the trust associated with director Margaret B. Pyle reported 36,891 Kewaunee Scientific common shares. This figure reflects indirect holdings after transferring 2,750 shares by gift to five grandchildren on March 26, 2026.

Does the Form 4 for Kewaunee Scientific (KEQU) show a market sale by Margaret B. Pyle?

The Form 4 shows no market sale by Margaret B. Pyle. It reports a bona fide gift of 2,750 indirectly held shares at a reported price of $0.0000 per share, indicating a non-market, no‑proceeds transfer to her grandchildren.

What indirect Kewaunee Scientific (KEQU) holdings by Margaret B. Pyle’s spouse are reported?

The filing reports 5,000 Kewaunee Scientific common shares held indirectly "By Spouse." This entry is categorized as a holding record, providing updated post-transaction indirect ownership information without indicating a buy or sell transaction code.

How many Kewaunee Scientific (KEQU) shares were gifted in total according to this Form 4?

According to the Form 4, a total of 2,750 Kewaunee Scientific common shares were transferred as a bona fide gift. The footnotes state these shares were gifted to five of the reporting person’s grandchildren on March 26, 2026.

What ownership disclaimers does Margaret B. Pyle make in the Kewaunee Scientific (KEQU) Form 4?

A footnote states that the reporting person disclaims beneficial ownership of the referenced shares. This indicates she does not claim full beneficial ownership, even though the shares are reported as indirectly held through related entities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PYLE MARGARET B

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NORTH CAROLINA 28677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		G		2,750	D	$0(1)	36,891	I	By Trust(2)
Common Stock								5,000	I	By Spouse(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On March 26, 2026, the reporting person transferred 2,750 shares of common stock by gift to five of the reporting person's grandchildren.

2. The reporting person disclaims beneficial ownership of these shares.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)